GFG Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
GFG Capital's PFE Position: Q3 2025 in Review
GFG Capital sold out of Pfizer (PFE) in Q3 2025, closing a stake of 549 shares — an estimated $13.3K sold.
GFG Capital first reported a position in PFE in Q4 2020 and held it in 10 quarters. The position peaked at $356K in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- GFG Capital reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- GFG Capital sold 549 Pfizer shares in Q3 2025, an estimated $13.3K.
- GFG Capital first reported a position in Pfizer in Q4 2020 and held it in 10 quarters.
- GFG Capital's Pfizer position peaked at $356K in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.